360 related articles for article (PubMed ID: 18729201)
21. Dehydration of risedronate hemi-pentahydrate: analytical and physical characterization.
Lester C; Lubey G; Dicks M; Andol G; Vaughn D; Cambron RT; Poiesz K; Redman-Furey N
J Pharm Sci; 2006 Dec; 95(12):2631-44. PubMed ID: 16917848
[TBL] [Abstract][Full Text] [Related]
22. Solid state characterization of E2101, a novel antispastic drug.
Kushida I; Ashizawa K
J Pharm Sci; 2002 Oct; 91(10):2193-202. PubMed ID: 12226846
[TBL] [Abstract][Full Text] [Related]
23. Solid-state properties and crystallization behavior of PHA-739521 polymorphs.
Sun CC
Int J Pharm; 2006 Aug; 319(1-2):114-20. PubMed ID: 16720086
[TBL] [Abstract][Full Text] [Related]
24. Rapid conversion of API hydrates to anhydrous forms in aqueous media.
Petrova RI; Peresypkin A; Mortko CJ; McKeown AE; Lee J; Williams JM
J Pharm Sci; 2009 Nov; 98(11):4111-8. PubMed ID: 19384923
[TBL] [Abstract][Full Text] [Related]
25. Effect of milling conditions on the solid-state conversion of ranitidine hydrochloride form 1.
Chieng N; Zujovic Z; Bowmaker G; Rades T; Saville D
Int J Pharm; 2006 Dec; 327(1-2):36-44. PubMed ID: 16949221
[TBL] [Abstract][Full Text] [Related]
26. Crystallization, spectral, crystallographical, and thermoanalytical studies of succinobucol polymorphism.
Jurček O; Lahtinen M; Wimmer Z; Drašar P; Kolehmainen E
J Pharm Sci; 2012 May; 101(5):1794-802. PubMed ID: 22323097
[TBL] [Abstract][Full Text] [Related]
27. Solid-state characterization of AG337 (Thymitaq), a novel antitumor drug.
Dash AK; Tyle P
J Pharm Sci; 1996 Oct; 85(10):1123-7. PubMed ID: 8897283
[TBL] [Abstract][Full Text] [Related]
28. An Integrated View of the Influence of Temperature, Pressure, and Humidity on the Stability of Trimorphic Cysteamine Hydrochloride.
Gana I; Barrio M; Ghaddar C; Nicolaï B; Do B; Tamarit JL; Safta F; Rietveld IB
Mol Pharm; 2015 Jul; 12(7):2276-88. PubMed ID: 26042338
[TBL] [Abstract][Full Text] [Related]
29. The role of molecular structure in the crystal polymorphism of local anesthetic drugs: crystal polymorphism of local anesthetic drugs, part X.
Schmidt AC
Pharm Res; 2005 Dec; 22(12):2121-33. PubMed ID: 16283568
[TBL] [Abstract][Full Text] [Related]
30. Solid-state study of mepivacaine hydrochloride.
Giannellini V; Bambagiotti-Alberti M; Bartolucci G; Bruni B; Coran SA; Costantino F; Di Vaira M
J Pharm Biomed Anal; 2005 Sep; 39(3-4):444-54. PubMed ID: 15950424
[TBL] [Abstract][Full Text] [Related]
31. Varenicline L-tartrate crystal forms: characterization through crystallography, spectroscopy, and thermodynamics.
Murphy BJ; Huang J; Casteel MJ; Cobani A; Krzyzaniak JF
J Pharm Sci; 2010 Jun; 99(6):2766-76. PubMed ID: 20091823
[TBL] [Abstract][Full Text] [Related]
32. Crystal forms of the hydrogen oxalate salt of o-desmethylvenlafaxine.
Dichiarante E; Curzi M; Giaffreda SL; Grepioni F; Maini L; Braga D
J Pharm Pharmacol; 2015 Jun; 67(6):823-9. PubMed ID: 25644936
[TBL] [Abstract][Full Text] [Related]
33. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
Jug M; Maestrelli F; Bragagni M; Mura P
J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
[TBL] [Abstract][Full Text] [Related]
34. Enantiotropically related polymorphs of gaboxadol hydrochloride.
Lopez de Diego H; Koradia V; Bond AD
Acta Crystallogr C; 2013 Nov; 69(Pt 11):1234-7. PubMed ID: 24192165
[TBL] [Abstract][Full Text] [Related]
35. New solvates of an old drug compound (phenobarbital): structure and stability.
Zencirci N; Griesser UJ; Gelbrich T; Kahlenberg V; Jetti RK; Apperley DC; Harris RK
J Phys Chem B; 2014 Mar; 118(12):3267-80. PubMed ID: 24571055
[TBL] [Abstract][Full Text] [Related]
36. Conformational polymorphism in aripiprazole: Preparation, stability and structure of five modifications.
Braun DE; Gelbrich T; Kahlenberg V; Tessadri R; Wieser J; Griesser UJ
J Pharm Sci; 2009 Jun; 98(6):2010-26. PubMed ID: 19009597
[TBL] [Abstract][Full Text] [Related]
37. Changes in the solid state of anhydrous and hydrated forms of sodium naproxen under different grinding and environmental conditions: Evidence of the formation of new hydrated forms.
Censi R; Rascioni R; Di Martino P
Eur J Pharm Biopharm; 2015 May; 92():192-203. PubMed ID: 25796350
[TBL] [Abstract][Full Text] [Related]
38. Identification and physicochemical characterization of caffeine-citric acid co-crystal polymorphs.
Mukaida M; Watanabe Y; Sugano K; Terada K
Eur J Pharm Sci; 2015 Nov; 79():61-6. PubMed ID: 26360836
[TBL] [Abstract][Full Text] [Related]
39. A study of variable hydration states in topotecan hydrochloride.
Vogt FG; Dell'Orco PC; Diederich AM; Su Q; Wood JL; Zuber GE; Katrincic LM; Mueller RL; Busby DJ; Debrosse CW
J Pharm Biomed Anal; 2006 Mar; 40(5):1080-8. PubMed ID: 16242889
[TBL] [Abstract][Full Text] [Related]
40. Polymorphism of tedisamil dihydrochloride.
Henck JO; Finner E; Burger A
J Pharm Sci; 2000 Sep; 89(9):1151-9. PubMed ID: 10944380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
